Table 4.
Multivariate analysis of the relation between in-hospital mortality and treatment in COVID-19
| Treatment | Multivariate analysis | |
|---|---|---|
| Odds ratio (95% CI) | P-value | |
| Metformin | 4.36 (1.22–15.59) | 0.02 |
| Statins | 2.98 (0.65–13.76) | 0.16 |
| Arbidol | 1.51 (0.60–3.84) | 0.38 |
| Lopinavir–ritonavir | 1.10 (0.33–3.63) | 0.88 |
| Chloroquine/hydroxychloroquine | 1.48 (0.17–12.53) | 0.72 |
| Ribavirin | 0.43 (0.12–1.51) | 0.19 |
| Interferon | 0.47 (0.13–1.66) | 0.24 |
| Chinese traditional medicine | 3.02 (1.22–7.51) | 0.02 |